Invivyd Inc (IVVD) Stock Analysis
Verdict: AVOID
Commercial biopharma with 46-month cash runway, but persistent operational losses and insider selling cap upside under $0.85.
Investment score: 34/100
Analysis as of
Is Invivyd Inc stock worth reviewing? The TradeMates thesis
Invivyd Inc combines a strong $226.7M cash balance (~46 months runway) with operational strain, reflected in TTM operating margin of -192.8% and consecutive 2026 earnings misses. With insiders liquidating shares near $0.72-$0.84 and the stock off 79% from 52-week highs, the model advises avoiding until trend reversal and operating break-even are established.
7-factor investment score
- Valuation: 35/100 (weight 20%)
- Financial Health: 60/100 (weight 15%)
- Technical Momentum: 15/100 (weight 15%)
- Earnings Quality: 15/100 (weight 15%)
- Insider Sentiment: 20/100 (weight 10%)
- Analyst Consensus: 55/100 (weight 10%)
- Risk-Adjusted Return: 25/100 (weight 15%)
Invivyd Inc opportunities and risks
What speaks for IVVD
- Extended Cash Runway of ~46 Months
What speaks against IVVD
- Severe Operational Unprofitability and Operating Loss Expansion
Peers and competitors
- ALEC
- WHWK
- RNAC
- SION
- UPB
- ELDN
- TRDA
- LYEL
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| IVVD | n/a | 3.3x | n/a | 91.4% | -183.9% | -57.6% |
| ALEC | n/a | 15.0x | n/a | 100.0% | -850.1% | -76.3% |
| WHWK | n/a | 0.0x | n/a | 0.0% | 0.0% | -40.3% |
| RNAC | n/a | 130.7x | n/a | -766.4% | -10422.5% | -40.5% |
| SION | n/a | 0.0x | n/a | 0.0% | 0.0% | -49.6% |
| UPB | n/a | 61.2x | n/a | 98.4% | -4955.7% | -70.6% |
| Peer median | n/a | 15.0x | n/a | 0.0% | -850.1% | -49.6% |
Frequently asked questions about Invivyd Inc (IVVD)
Is IVVD stock a good investment?
The TradeMates model rates Invivyd Inc as AVOID with an investment score of 34/100. Invivyd Inc combines a strong $226.7M cash balance (~46 months runway) with operational strain, reflected in TTM operating margin of -192.8% and consecutive 2026 earnings misses. With insiders liquidating shares near $0.72-$0.84 and the stock off 79% from 52-week highs, the model advises avoiding until trend reversal and operating break-even are established. This is algorithmic model output, not personal investment advice.
Is IVVD stock a buy?
The TradeMates model verdict for IVVD is AVOID with an investment score of 34/100. Treat this as a model signal to review, not a personal buy recommendation.